This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Killer acquisitions, ‘potential competition’ cases in US states’ sights, Wisconsin official says

By Michael Acton ( March 31, 2023, 18:00 GMT | Insight) -- US state enforcers are concerned about killer acquisitions, including in the pharmaceutical industry, Gwendolyn Cooley, Wisconsin’s assistant attorney general for antitrust and chair of the states’ antitrust task force, said. Following the Federal Trade Commission’s unsuccessful bid to block Meta Platforms’ acquisition of VR app developer Within, Cooley also said companies can expect more such challenges to vertical deals based on the theory that an acquisition will eliminate potential competition because the buyer opts not to enter the same market with a competing product. US state enforcers are concerned about killer acquisitions, including in the pharmaceutical industry, Gwendolyn Cooley, Wisconsin’s assistant attorney general for antitrust and chair of the states’ antitrust task force, said....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login